Addex Therapeutics (ADXN) Earnings Analysis

Addex Therapeutics (ADXN) next reports earnings on 2026-08-24. It has beaten estimates in 1/5 recent quarters (20%). Trailing P/E -0.72.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ADXN next report earnings?

Next earnings date2026-08-24
Consensus EPS estimaten/a
Revenue estimaten/a

ADXN earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-06-25-1.53 USDn/an/an/a
2026-04-30-1.93751 USD-1.42459 USD-36%Miss
2025-12-04-1.5 USDn/an/an/a
2025-06-20-1.33 USD-4.2591 USD+68.8%Beat
2025-04-07-1.62858 USD-1.4197 USD-14.7%Miss
2024-11-22-2.77 USD-1.4 USD-97.9%Miss
2024-09-30-1.77 USD-0.01 USD-17600%Miss

Beat rate: 1/5 (20%) over reported quarters with consensus data.

ADXN valuation and analyst view

Trailing P/E-0.72
Trailing EPS-4.88 USD
Price / book2.07
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (1 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Addex Therapeutics (ADXN)'s next earnings date?

Addex Therapeutics is next scheduled to report on 2026-08-24.

Did ADXN beat earnings last quarter?

Consensus estimate data was not available for ADXN's 2026-06-25 report.

What is ADXN's earnings track record?

Over the last 5 reported quarters with consensus data, ADXN beat estimates 1 times (20%).

What is ADXN's current P/E ratio and EPS?

ADXN trades at a trailing P/E of -0.72 on trailing EPS of -4.88 USD.

What do analysts rate ADXN?

Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell).